Get the Daily Brief
Latest Biotech News
MDxHealth Bolsters Prostate Cancer Diagnostics with Exosome Acquisition
MDxHealth announced a $15 million acquisition of Bio-Techne's Exosome Diagnostics, including the CLIA-certified ExoDx Prostate test. The deal aims to enhance MDxHealth’s revenue growth and expand...
Breakthrough in Bacterial Therapy Achieves Immune-Independent Tumor Destruction
Researchers at JAIST, Daiichi Sankyo, and University of Tsukuba developed a bacterial consortium therapy, AUN, demonstrating complete tumor remission in both immunocompetent and immunocompromised...
Twist Bioscience Revises 2025 Outlook After Record Synthetic Biology and NGS Revenues
Twist Bioscience reported $96.1 million in Q3 2025 revenues, up 18% year-over-year, driven by 7% growth in synthetic biology products and 27% growth in next-generation sequencing. The company sold...
Replimmune’s Melanoma Drug Faces FDA Rejection Amid Internal Agency Conflict
Replimmune’s oncolytic immunotherapy RP1 for advanced melanoma was rejected by the FDA, with the agency’s top cancer regulator Richard Pazdur reportedly overriding CBER staff consensus. Concerns...
FDA Device User Fee Negotiations Highlight Industry and Agency Divergences
Negotiations for the sixth FDA Device User Fee Agreement (MDUFA VI) have commenced, revealing notable discrepancies between regulatory agency expectations and industry demands. Proposed fee...
Quantum Teleportation Achieves Record Distance Over Fiber Networks
A photonic quantum teleportation was successfully performed over 12.3 kilometers of optical fiber, marking a significant milestone for scalable quantum communication networks. The experiment...
Sophia Genetics Expands AI Collaboration With AstraZeneca, Posts 16% Revenue Gain
Sophia Genetics reported a 16% year-over-year revenue increase to $18.3 million in Q2 2025, driven by growth outside the biopharma sector. The company expanded its collaboration with AstraZeneca...
Herbal and Natural Products Show Promise in Cancer and Infectious Disease Treatment
Multiple studies reveal the anticancer and antiparasitic potential of natural compounds. Ursolic acid demonstrates activity against breast cancer via the PLK1 pathway, quinoa terpenoids inhibit...
Breakthrough in Programmable Chromosome Engineering Enables Megabase-Scale Genome Editing
Chinese researchers led by Professor Gao Caixia developed programmable chromosome engineering (PCE) systems achieving precision editing at megabase scale in eukaryotic cells. Their innovations...
FDA Cancer Regulator Stops Replimmune's Melanoma Drug Amid Internal Disputes
The FDA's Oncology Center of Excellence director, Richard Pazdur, intervened late in the review of Replimmune's melanoma therapy RP1, contributing to its rejection despite earlier support within...
Twist Bioscience Reports Record Q3 Revenues, Narrows 2025 Guidance
Twist Bioscience posted an 18 percent year-over-year revenue increase in Q3 2025, driven by growth in next-generation sequencing and synthetic biology sectors. Despite this, the company slightly...
Vertex Pharmaceuticals Faces Setbacks in Pain Drug Development
Vertex Pharmaceuticals reported a Phase 2 failure for its next-generation non-opioid pain candidate VX-993, which did not outperform placebo in bunionectomy pain, leading the company to...
Sophia Genetics Expands Collaboration with AstraZeneca, Reports 16% Revenue Growth
Sophia Genetics reported a 16 percent year-over-year revenue increase for Q2 2025, fueled by robust molecular analyses on its AI-driven platform. The company announced an expanded multi-year...
Emerging Therapies and Advances in Cancer Immunotherapy and Oncology
Significant advancements in oncology include: UNC Lineberger’s symposium highlighting progress in cancer research; novel dual-target therapies aiming at colorectal and breast cancers; innovative...
Microplastics and Nanoplastics: Environmental and Human Health Insights
Recent studies reveal micro- and nanoplastics' pervasive presence across ecosystems and human tissues, with advances in detection technologies such as AI and Raman spectroscopy improving...
Glucagon-Like Peptide-1 (GLP-1) Drugs: Clinical Effects and Coverage Developments
New research suggests that GLP-1 receptor agonists like semaglutide may reduce muscle strength in mice despite stable muscle size, raising questions for older populations. Policy shifts in the US...
Biotech Industry Funding, Partnerships, and Workforce Challenges
The life sciences sector faces a mixed landscape, with major funding rounds closing as OrbiMed raises $1.86 billion for its fifth fund and Abbivax, MapLight, Everest Medicines secure significant...
Innovations in Energy Storage and Battery Technology
Researchers report groundbreaking advancements in battery materials, including the development of novel sodium-ion cathodes via combustion synthesis and enhanced lithium-ion cathodes through...
Groundbreaking Genomic and Protein Engineering Technologies
Chinese scientists achieved megabase-scale precise genome editing in eukaryotic cells using programmable chromosome engineering platforms, overcoming limitations of Cre-Lox systems through...
Tariffs Hit Pharma Imports as Trump Signals Up to 250% Levies
The U.S. administration under former President Donald Trump has announced plans to impose escalating tariffs on pharmaceutical imports, starting with a small duty and potentially rising to 250%...